Tag Archives: REGN

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), Incyte (NASDAQ: INCY) and Inogen (NASDAQ: INGN)

Analysts fell to the sidelines weighing in on Regeneron (REGN – Research Report), Incyte (INCY – Research Report) and Inogen (INGN – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Regeneron

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN) and Premier (NASDAQ: PINC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN – Research Report) and Premier (PINC – Research Report). Regeneron (REGN) In a report released yesterday, Evan Seigerman from Credit Suisse reiterated a

Analysts Offer Insights on Healthcare Companies: Regeneron (NASDAQ: REGN), ACADIA Pharmaceuticals (NASDAQ: ACAD) and Premier (NASDAQ: PINC)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Regeneron (REGN – Research Report), ACADIA Pharmaceuticals (ACAD – Research Report) and Premier (PINC – Research Report) with bullish sentiments. Regeneron (REGN)

Morgan Stanley Remains a Hold on Regeneron (REGN)

Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Regeneron (REGN – Research Report) today and set a price target of $409.00. The company’s shares closed last Wednesday at $517.67, close to its 52-week high of $525.91. According to

Regeneron (REGN) Received its Third Buy in a Row

After Evercore ISI and Piper Sandler gave Regeneron (NASDAQ: REGN) a Buy rating last month, the company received another Buy, this time from Canaccord Genuity. Analyst John Newman initiated coverage with a Buy rating on Regeneron yesterday and set a

Regeneron (REGN) Gets a Buy Rating from Argus Research

In a report released today, Jasper Hellweg from Argus Research maintained a Buy rating on Regeneron (REGN – Research Report), with a price target of $540.00. The company’s shares closed last Monday at $447.80. According to TipRanks.com, Hellweg is a